Senhwa Biosciences Receives NT$500 Million Commitment from GEM for AI-Driven Drug Development
Senhwa Biosciences has signed an MOU with GEM Yield Bahamas for up to NT$500 million in funding to support its AI-enabled drug discovery and global expansion.